InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-04-09 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
| 2024-06-21 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
| 2024-04-04 | Josh Gottheimer(D-NJ05) | house | Sale | $1,001 - $15,000 |
| 2023-08-18 | Josh Gottheimer(D-NJ05) | house | Purchase | $1,001 - $15,000 |
| 2023-07-10 | Daniel Goldman(D-NY10) | house | Sale | $1,001 - $15,000 |
No financial data available for CHGCY.
Company may not file with SEC or CIK is unresolved.
Earnings Season, Tehran Proposal Lift Asian Stock Markets
Chugai Pharmaceutical Co., Ltd. (CHGCY) Q1 2026 Earnings Call Transcript
Chugai Pharmaceutical Co., Ltd. 2026 Q1 - Results - Earnings Call Presentation
Is Chugai Pharmaceutical (TSE:4519) Still Attractively Priced After Its Strong Multi Year Run
Mitsubishi Electric Announces Director Candidates
Rani Therapeutics Q4 Earnings Call Highlights
Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate Update
Roche stops work on experimental SMA drug
Why Sarepta Therapeutics (SRPT) Is Down 11.2% After CEO Retirement Plan And Japan Gene Therapy Launch - And What's Next
Sarepta Therapeutics Announces Commercial Launch of ELEVIDYS in Japan
Chugai Pharmaceutical Co., Ltd. (CHGCY) Q4 2025 Earnings Call Transcript
Chugai Pharmaceutical reports FY results